MobileODT, an Israeli Digital Health FemTech company’s latest innovation in cervical cancer screening, Visual Check AI technology, is supporting a large-scale, government cervical cancer screening project in the Dominican Republic. Initially, concept project proof was part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. Currently, the project is run by the Dominican Republic Ministry of Health in cooperation with MobileODT.
In the past three months, the project succeeded at screening 9,000 women from cervical cancer with the EVA Visual Check AI technology, which further expand this program to cover another 50,000 women who are due to be screened over the next six months. VisualCheck provides non-specialists with an AI clinical decision support tool, predicting how highly trained colposcopies would determine positive or negative cervical cancer diagnosis.
Dr. Alfredo Levy, MD, OBGYN, one of the leading physicians involved in this project, said: “Many cervical cancer cases happen due to a lack of timely follow-up. The ability to receive the results immediately at the point of care is a complete game-changer. The EVA VisualCheck system is quick and easy to use, allowing us to screen more patients and predict results with high accuracy.”
Leon Boston, CEO, MobileODT, said: “We are the only company in the world with an AI capability in cervical cancer screening. Our unique AI algorithm allows an unprecedented screening scale that can be life-saving for so many women globally. We are currently amid funding round, to support our long-term strategy and expand to broader areas in women’s health with AI technology.”